This is in keeping with studies which found that increased infiltration of CD163 was associated with poorer OS in hepatocellular carcinoma, triple negative breast cancer and follicular lymphoma [58, 59, 60]. This evidence concerns the gene CD163 and hepatocellular carcinoma.